Introduction. Background: Neurocysticercosis (NCC), a parasitic disease caused by the pork tapeworm Taenia solium (T. solium), is a significant public health concern in endemic countries. It is estimated to contribute to roughly 30% of all epilepsy cases and leads to chronic morbidity in nearly 70% of affected patients. This study aimed to determine the prevalence of anti-cysticercus antibodies to T. solium in individuals with recent-onset seizures. We employed two serological techniques: Enzyme-Linked Immuno Sorbent Assay (ELISA) and Enzyme-Linked Immuno Transfer Blot (EITB). Materials and Methods: A total of 100 serum samples were collected: 50 from patients experiencing recent-onset seizures (cases) and 50 from age-matched healthy controls. All samples were analyzed for the presence of anti-cysticercus antibodies to T. solium. Results: Among the 50 cases, EITB detected anti-cysticercus antibodies in six patients (12%), while ELISA identified antibodies in three patients (6%). Notably, only two cases tested positive using both EITB and ELISA. In the control group, one individual was seropositive by EITB, and none were positive by ELISA. Conclusion: This study underscores the critical role of implementing high-quality screening methods, employing a vigilant diagnostic approach, and taking prompt preventive measures to mitigate the burden of morbidity associated with NCC.
No takes yet. Share an insight, caveat, or question.
Durairaj et al. (2024) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: